Arabic
English
Quick links
Government sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password?

تاريخ جدول الأعمال مقررات اللجنة
12-11-2015 Agenda12.11.2015  
11-11-2015 Agenda11.11.2015  
22-10-2015 Agenda22.10.2015 Decisions22.10.2015
21-10-2015 Agenda21.10.2015 Decisions21.10.2015
20-10-2015 Agenda20.10.2015 Decisions20.10.2015
19-10-2015 Agenda19.10.2015 Decisions19.10.2015
8-10-2015 Agenda8.10.2015 Decisions8.10.2015
7-10-2015 Agenda7.10.2015 Decisions7.10.2015
30-9-2015 Agenda30.9.2015 Decisions30.9.2015
29-9-2015 Agenda29.9.2015 Decisions29.9.2015
16-9-2015 Agenda16.9.2015 Decisions16.9.2015
15-9-2015 Agenda15.9.2015 Decisions15.9.2015
2-9-2015 Agenda2.9.2015 Decisions2.9.2015
1-9-2015 Agenda1.9.2015 Decisions1.9.2015
20-8-2015 Agenda20.8.2015 Decisions20.8.2015
19-8-2015 Agenda19.8.2015 Decisions19.8.2015
13-8-2015 Agenda13.8.2015 Decisions13.8.2015
12-8-2015 Agenda12.8.2015 Decisions12.8.2015
6-8-2015 Agenda6.8.2015 Decisions6.8.2015
5-8-2015 Agenda5.8.2015 Decisions5.8.2015
29-7-2015 Agenda29.7.2015 Decisions29.7.2015
28-7-2015 Agenda28.7.2015 Decisions28.7.2015
15-7-2015 Agenda15.7.2015 Decisions15.7.2015
14-7-2015 Agenda14.7.2015 Decisions14.7.2015
8-7-2015 Agenda8.7.2015 Decisions8.7.2015
7-7-2015 Agenda7.7.2015 Decisions7.7.2015
25-6-2015 Agenda25.6.2015 Decisions25.6.2015
24-6-2015 Agenda24.6.2015 Decisions24.6.2015
5-6-2015 Agenda5.6.2015 Decisions5.6.2015
4-6-2015 Agenda4.6.2015 Decisions4.6.2015
2-6-2015 Agenda2.6.2015 Decisions2.6.2015
1-6-2015 Agenda1.6.2015 Decisions1.6.2015
28-5-2015 Agenda28.5.2015 Decisions28.5.2015
27-5-2015 Agenda27.5.2015 Decisions27.5.2015
14-5-2015 Agenda14.5.2015 Decisions14.5.2015
13-5-2015 Agenda13.5.2015 Decisions13.5.2015
5-5-2015 Agenda5.5.2015 Decisions5.5.2015
4-5-2015 Agenda4.5.2015 Decisions4.5.2015
23-4-2015 Agenda23.4.2015 Decisions23.4.2015
22-4-2015 Agenda22.4.2015 Decisions22.4.2015
21-4-2015 Agenda21.4.2015 Decisions21.4.2015
20-4-2015 Agenda20.4.2015 Decisions20.4.2015
16-4-2015 Agenda16.4.2015 Decisions16.4.2015
15-4-2015 Agenda15.4.2015 Decisions15.4.2015
19-3-2015 Agenda19.3.2015 Decisions19.3.2015
18-3-2015 Agenda18.3.2015 Decisions18.3.2015
12-3-2015 Agenda12.3.2015 Decisions12.3.2015
11-3-2015 Agenda11.3.2015 Decisions11.3.2015
6-3-2015 Agenda6.3.2015 Decisions6.3.2015
5-3-2015 Agenda5.3.2015 Decisions5.3.2015
20-2-2015 Agenda20.2.2015 Decisions20.2.2015
19-2-2015 Agenda19.2.2015 Decisions19.2.2015
18-2-2015 Agenda18.2.2015 Decisions18.2.2015
17-2-2015 Agenda17.2.2015 Decisions17.2.2015
12-2-2015 Agenda12.2.2015 Decisions12.2.2015
11-2-2015 Agenda11.2.2015 Decisions11.2.2015
17-1-2015 Agenda17.1.2015 Decisions17.1.2015
16-1-2015 Agenda16.1.2015 Decisions16.1.2015
13-1-2015 Agenda13.1.2015 Decisions13.1.2015
12-1-2015 Agenda12.1.2015 Decisions12.1.2015
7-1-2015 Agenda7.1.2015 Decisions7.1.2015
5-1-2015 Agenda5.1.2015 Decisions5.1.2015
30-12-2014 Agenda30.12.2014 Decisions30.12.2014
29-12-2014 Agenda29.12.2014 Decisions29.12.2014
18-12-2014 Agenda18.12.2014 Decisions18.12.2014
17-12-2014 Agenda17.12.2014 Decisions17.12.2014
3-12-2014 Agenda3.12.2014 Decisions3.12.2014
2-12-2014 Agenda2.12.2014 Decisions2.12.2014
20-11-2014 Agenda20.11.2014 Decisions20.11.2014
19-11-2014 Agenda19.11.2014 Decisions19.11.2014
13-11-2014 Agenda13.11.2014 Decisions13.11.2014
12-11-2014 Agenda12.11.2014 Decisions12.11.2014
5-11-2014 Agenda5.11.2014 Decisions6.11.2014
4-11-2014 Agenda4.11.2014 Decisions5.11.2014
14-10-2014 Agenda14.10.2014 Decisions14.10.2014
13-10-20104 Agenda13.10.2014 Decisions13.10.2014
11-10-2014 Agenda11.10.2014 Decisions11.10.2014
10-10-2014 Agenda10.10.2014 Decisions10.10.2014
3-10-2014 Agenda3.10.2014 Decisions3.10.2014
2-10-2014 Agenda2.10.2014 Decisions2.10.2014
30-9-2014 Agenda30.9.2014 Decisions30.9.2014
29-9-2014 Agenda29.9.2014 Decisions29.9.2014
18-9-2014 Agenda18.9.2014 Decisions18.9.2014
17-9-2014 Agenda17.9.2014 Decisions17.9.2014
5-9-2014 Agenda5.9.2014 Decisions5.9.2014
4-9-2014 Agenda4.9.2014 Decisions4.9.2014
27-8-2014 Agenda27.8.2014 Decisions27.8.2014
26-8-2014 Agenda26.8.2014 Decisions26.8.2014
20-8-2014 Agenda20.8.2014 Decisions20.8.2014
19-8-2014 Agenda19.8.2014 Decisions19.8.2014
13-8-2014 Agenda13.8.2014 Decisions13.8.2014
12-8-2014 Agenda12.8.2014 Decisions12.8.2014
24-7-2014 Agenda24.7.2014 Decisions24.7.2014
23-7-2014 Agenda23.7.2014 Decisions23.7.2014
16-7-2014 Agenda16.7.2014 Decisions16.7.2014
15-7-2014 Agenda15.7.2014 Decisions15.7.2014
10-7-2014 Agenda10.7.2014 Decisions10.7.2014
9-7-2014 Agenda9.7.2014 Decisions9.7.2014
25-6-2014 Agenda25.6.2014 Decisions25.6.2014
23-6-2014 Agenda23.6.2014 Decisions23.6.2014
16-6-2014 Agenda16.6.2014 Decisions16.6.2014
9-6-2014 Agenda9.6.2014 Decisions9.6.2014
31-5-2014 Agenda31.5.2014 Decisions31.5.2014
30-5-2014 Agenda30.5.2014 Decisions30.5.2014
21-5-2014 Agenda21.5.2014 Decisions21.5.2014
20-5-2014 Agenda20.5.2014 Decisions20.5.2014
14-5-2014 Agenda14.5.2014 Decisions14.5.2014
13-5-2014 Agenda13.5.2014 Decisions13.5.2014
25-4-2014 Agenda25.4.2014 Decisions25.4.2014
24-4-2014 Agenda24.4.2014 Decisions24.4.2014
23-4-2014 Agenda23.4.2014 Decisions23.4.2014
22-4-2014 Agenda22.4.2014 Decisions22.4.2014
8-4-2014 Agenda8.4.2014 Decisions8.4.2014
7-4-2014 Agenda7.4.2014 Decisions7.4.2014
11-3-2014 Agenda11.3.2014 Decisions11.3.2014
10-3-2014 Agenda10.3.2014 Decisions10.3.2014
8-3-2014 Agenda8.3.2014 Decisions8.3.2014
7-3-2014 Agenda7.3.2014 Decisions7.3.2014
6-3-2014 Agenda6.3.2014 Decisions6.3.2014
5-3-2014 Agenda5.3.2014 Decisions5.3.2014
26-2-2014 Agenda26.2.2014 Decisions26.2.2014
25-2-2014 Agenda25.2.2014 Decisions25.2.2014
12-2-2014 Agenda12.2.2014 Decisions12.2.2014
11-2-2014 Agenda11.2.2014 Decisions11.2.2014
18-1-2014 Agenda18.1.2014 Decisions18.1.2014
17-1-2014 Agenda17.1.2014 Decisions17.1.2014
16-1-2014 Agenda16.1.2014 Decisions16.1.2014
15-1-2014 Agenda15.1.2014 Decisions15.1.2014
3-1-2014 Agenda3.1.2014 Decisions3.1.2014
2-1-2014 Agenda2.1.2014 Decisions2.1.2014
    1
    2
    3
    4
    5
    6
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC brand_name B/G Ingredients Dosage ↑ Form Price
A10BD19 GLYXAMBI B Linagliptin - 5mg, Empagliflozin - 10mg Tablet, film coated 4,482,387 L.L
A10BD19 GLYXAMBI B Linagliptin - 5mg, Empagliflozin - 10mg Tablet, film coated 4,482,387 L.L
A10BD19 GLYXAMBI B Linagliptin - 5mg, Empagliflozin - 25mg Tablet, film coated 4,482,387 L.L
A10BD19 GLYXAMBI B Linagliptin - 5mg, Empagliflozin - 25mg Tablet, film coated 4,482,387 L.L
N02BE51 GENTLE RELIEF G Paracetamol - 325mg, Ibuprofen - 400mg, Famotidine - 20mg Tablet 184,106 L.L
S01ED51 GANFORT B Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml Drops solution 950,097 L.L
S01ED51 GANFORT B Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml Drops solution 950,097 L.L
D07CC02 GENTACORT-FC G Fluocinolone acetonide - 0.01%, Clotrimazole - 1%, Gentamicin (sulfate) - 0.1% Cream 302,365 L.L
J05AR18 GENVOYA B Emtricitabine - 200mg, Tenofovir alafenamide - 10mg, Elvitegravir - 150mg, Cobicistat - 150mg Tablet, film coated 77,789,650 L.L
B03AD03 GYNO-TARDYFERON B Folic acid - 0.35mg, Ferrous (sulfate) - 80mg Tablet, sugar coated, slow release 819,744 L.L
C05CA54 GINKOR FORT B Heptaminol HCl - 0.300g, Troxerutine - 0.300g, Ginkgo biloba extract - 0.014g Capsule 681,328 L.L
J07BB01 GC FLU QUADRIVALENT INFLUENZA VACCINE G Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml Injectable suspension 791,523 L.L
A02BX13 GAVISCON B Sodium alginate - 500mg/10ml, Sodium bicarbonate - 267mg/10ml, Calcium (carbonate) - 160mg/10ml Liquid 295,645 L.L
A02BX13 GAVISCON INFANT B Sodium alginate - 225mg, Magnesium alginate - 87.5mg Powder for suspension 710,893 L.L
A02BX13 GAVISCON ADVANCE ANISEED FLAVOR B Sodium alginate - 1000mg/10ml, Potassium hydrogen carbonate - 200mg/10ml Suspension 514,692 L.L
A02BX13 GAVISCON DOUBLE ACTION MINT B Sodium alginate - 250mg, Sodium bicarbonate - 106.5mg, Calcium (carbonate) - 187.5mg Tablet, chewable 456,906 L.L
A02BX13 GAVISCON DOUBLE ACTION MINT B Sodium alginate - 500mg/10ml, Sodium bicarbonate - 213mg/10ml, Calcium (carbonate) - 325mg/10ml Suspension 542,912 L.L
A02BX13 GAVISCON DOUBLE ACTION B Sodium alginate - 500mg, Sodium bicarbonate - 213mg, Calcium (carbonate) - 325mg Suspension 517,379 L.L
A02BX13 GAVISCON PEPPERMINT LIQUID B Sodium alginate - 250mg/10ml, Sodium bicarbonate - 133.5mg/10ml, Calcium (carbonate) - 80mg/10ml Suspension 393,746 L.L
J07BM03 GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT B Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml Injectable suspension 14,139,396 L.L
C09DA04 GIZLAN-PLUS G Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 395,090 L.L
C09DA04 GIZLAN-PLUS G Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 395,090 L.L
C09DA04 GIZLAN-PLUS G Irbesartan - 300mg, Hydrochlorothiazide - 25mg Tablet, film coated 768,678 L.L
G01AA51 GYNAMEND G Nystatin - 100,000IU, Neomycin (sulfate) - 35,000IU, Polymyxin B sulfate - 35,000IU Capsule, soft 345,560 L.L
R02AA05 GOLASEPTINE-LIDOCAINE G Chlorhexidine HCl - 5mg, Lidocaine HCl - 1mg Tablet, chewable 736,426 L.L
D02AX GLYCERINE G Glycerol - Liquid 163,821 L.L
A10BD02 GLUCOVANCE B Metformin HCl - 500mg, Glibenclamide - 2.5mg Tablet, film coated 563,663 L.L
A10BD02 GLYSTOR PLUS G Metformin HCl - 500mg, Glibenclamide - 2.5mg Tablet, film-scored 533,697 L.L
A10BD02 GLUCOVANCE B Metformin HCl - 500mg, Glibenclamide - 5mg Tablet, film coated 775,971 L.L
A10BD02 GLYSTOR PLUS G Metformin HCl - 500mg, Glibenclamide - 5mg Tablet, film-scored 691,119 L.L
    1
    2
    3
    4
    5
    6
Sitemap
© Copyrights reserved to Ministry of Public Health 2026